FORM 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2009
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number : 001-31911
American Equity Investment Life Holding Company
(Exact name of registrant as specified in its charter)
Iowa |
|
42-1447959 |
(State of Incorporation) |
|
(I.R.S. Employer Identification No.) |
|
|
|
5000 Westown Parkway, Suite 440 |
|
|
West Des Moines, Iowa |
|
50266 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone number, including area code |
|
(515) 221-0002 |
|
|
(Telephone) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Name of each exchange on which registered |
Common Stock, par value $1 |
|
New York Stock Exchange |
Securities registered pursuant to Section 12(g) of the Act: Common Stock, par value $1
Indicate by check mark whether the registrant (1) has filed all documents and reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 504 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of large accelerated filer, accelerated filer, and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer o |
|
Accelerated filer x |
|
|
|
Non-accelerated
filer o |
|
Smaller reporting company o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.) Yes o No x
Shares of common stock outstanding at October 30, 2009: 58,294,559
PART I FINANCIAL INFORMATION
Item 1. Financial Statements
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except per share data)
|
|
September 30, |
|
December 31, |
|
||
|
|
(Unaudited) |
|
(As Adjusted) |
|
||
|
|
|
|
|
|
||
Assets |
|
|
|
|
|
||
Investments: |
|
|
|
|
|
||
Fixed maturity securities: |
|
|
|
|
|
||
Available for sale, at fair value (amortized cost: 2009 - $11,147,379; 2008 - $7,159,286) |
|
$ |
11,082,957 |
|
$ |
6,629,046 |
|
Held for investment, at amortized cost (fair value: 2009 - $1,746,033; 2008 - $3,588,114) |
|
1,758,747 |
|
3,604,149 |
|
||
Equity securities, available for sale, at fair value (cost: 2009 - $84,512; 2008 - $125,157) |
|
94,076 |
|
99,552 |
|
||
Trading securities |
|
371,338 |
|
|
|
||
Mortgage loans on real estate |
|
2,375,833 |
|
2,329,824 |
|
||
Derivative instruments |
|
364,041 |
|
56,588 |
|
||
Other investments |
|
9,332 |
|
446 |
|
||
Total investments |
|
16,056,324 |
|
12,719,605 |
|
||
|
|
|
|
|
|
||
Cash and cash equivalents |
|
249,862 |
|
214,862 |
|
||
Restricted cash and short-term investments |
|
177,149 |
|
|
|
||
Coinsurance deposits |
|
2,010,084 |
|
1,528,981 |
|
||
Accrued investment income |
|
132,621 |
|
91,756 |
|
||
Deferred policy acquisition costs |
|
1,553,709 |
|
1,579,871 |
|
||
Deferred sales inducements |
|
936,512 |
|
843,377 |
|
||
Deferred income taxes |
|
143,773 |
|
82,409 |
|
||
Other assets |
|
36,445 |
|
20,879 |
|
||
Total assets |
|
$ |
21,296,479 |
|
$ |
17,081,740 |
|
2
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
CONSOLIDATED BALANCE SHEETS (Continued)
(Dollars in thousands, except per share data)
|
|
September 30, |
|
December 31, |
|
||
|
|
(Unaudited) |
|
(As Adjusted) |
|
||
Liabilities and Stockholders Equity |
|
|
|
|
|
||
Liabilities: |
|
|
|
|
|
||
Policy benefit reserves: |
|
|
|
|
|
||
Traditional life and accident and health insurance products |
|
$ |
134,490 |
|
$ |
121,914 |
|
Annuity products |
|
18,331,332 |
|
15,687,625 |
|
||
Other policy funds and contract claims |
|
110,690 |
|
111,205 |
|
||
Notes payable |
|
287,697 |
|
247,750 |
|
||
Subordinated debentures |
|
268,312 |
|
268,209 |
|
||
Amounts due under repurchase agreements |
|
410,254 |
|
|
|
||
Funds withheld reinsurance liability |
|
463,100 |
|
|
|
||
Income taxes payable |
|
25,631 |
|
14,133 |
|
||
Other liabilities |
|
513,689 |
|
134,060 |
|
||
Total liabilities |
|
20,545,195 |
|
16,584,896 |
|
||
|
|
|
|
|
|
||
Stockholders equity: |
|
|
|
|
|
||
Common stock, par value $1 per share, 125,000,000 shares authorized; issued and outstanding: 2009 - 56,203,159 shares (excluding 5,936,696 treasury shares); 2008 - 50,739,355 shares (excluding 6,263,700 treasury shares) |
|
56,203 |
|
50,739 |
|
||
Additional paid-in capital |
|
406,234 |
|
376,782 |
|
||
Unallocated common stock held by ESOP: 2009 - 563,265 shares; 2008 - 588,312 shares |
|
(5,930 |
) |
(6,336 |
) |
||
Accumulated other comprehensive income (loss) |
|
14,011 |
|
(147,376 |
) |
||
Retained earnings |
|
280,766 |
|
223,035 |
|
||
Total stockholders equity |
|
751,284 |
|
496,844 |
|
||
Total liabilities and stockholders equity |
|
$ |
21,296,479 |
|
$ |
17,081,740 |
|
See accompanying notes to unaudited consolidated financial statements.
3
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in thousands, except per share data)
(Unaudited)
|
|
Three Months Ended |
|
Nine Months Ended |
|
||||||||
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
|
||||
|
|
|
|
(As Adjusted) |
|
|
|
(As Adjusted) |
|
||||
Revenues: |
|
|
|
|
|
|
|
|
|
||||
Traditional life and accident and health insurance premiums |
|
$ |
3,166 |
|
$ |
3,223 |
|
$ |
9,519 |
|
$ |
9,419 |
|
Annuity product charges |
|
15,835 |
|
13,328 |
|
47,501 |
|
37,271 |
|
||||
Net investment income |
|
241,471 |
|
209,978 |
|
688,928 |
|
607,546 |
|
||||
Change in fair value of derivatives |
|
121,507 |
|
(83,753 |
) |
108,178 |
|
(314,431 |
) |
||||
Net realized gains on investments, excluding other than temporary impairment (OTTI) losses |
|
5,510 |
|
2,258 |
|
10,587 |
|
3,343 |
|
||||
OTTI losses on investments: |
|
|
|
|
|
|
|
|
|
||||
Total OTTI losses |
|
(94,216 |
) |
(61,232 |
) |
(171,668 |
) |
(94,755 |
) |
||||
Portion of OTTI losses recognized in other comprehensive income |
|
49,641 |
|
|
|
108,012 |
|
|
|
||||
Net OTTI losses recognized in operations |
|
(44,575 |
) |
(61,232 |
) |
(63,656 |
) |
(94,755 |
) |
||||
Gain (loss) on extinguishment of debt |
|
|
|
(28 |
) |
3,098 |
|
(1,356 |
) |
||||
Total revenues |
|
342,914 |
|
83,774 |
|
804,155 |
|
247,037 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Benefits and expenses: |
|
|
|
|
|
|
|
|
|
||||
Insurance policy benefits and change in future policy benefits |
|
2,737 |
|
2,126 |
|
6,910 |
|
7,056 |
|
||||
Interest sensitive and index product benefits |
|
75,288 |
|
50,387 |
|
207,028 |
|
154,032 |
|
||||
Amortization of deferred sales inducements |
|
(8,081 |
) |
6,760 |
|
17,814 |
|
34,193 |
|
||||
Change in fair value of embedded derivatives |
|
259,737 |
|
(37,100 |
) |
414,636 |
|
(237,969 |
) |
||||
Interest expense on notes payable |
|
3,370 |
|
5,014 |
|
11,288 |
|
15,127 |
|
||||
Interest expense on subordinated debentures |
|
3,841 |
|
4,669 |
|
12,078 |
|
14,549 |
|
||||
Interest expense on amounts due under repurchase agreements |
|
100 |
|
2,698 |
|
344 |
|
7,694 |
|
||||
Amortization of deferred policy acquisition costs |
|
(2,972 |
) |
19,285 |
|
44,938 |
|
118,595 |
|
||||
Other operating costs and expenses |
|
13,961 |
|
13,549 |
|
45,305 |
|
38,550 |
|
||||
Total benefits and expenses |
|
347,981 |
|
67,388 |
|
760,341 |
|
151,827 |
|
||||
Income (loss) before income taxes |
|
(5,067 |
) |
16,386 |
|
43,814 |
|
95,210 |
|
||||
Income tax expense (benefit) |
|
(2,089 |
) |
28,102 |
|
11,305 |
|
55,214 |
|
||||
Net income (loss) |
|
$ |
(2,978 |
) |
$ |
(11,716 |
) |
$ |
32,509 |
|
$ |
39,996 |
|
|
|
|
|
|
|
|
|
|
|
||||
Earnings (loss) per common share |
|
$ |
(0.05 |
) |
$ |
(0.22 |
) |
$ |
0.59 |
|
$ |
0.74 |
|
Earnings (loss) per common share - assuming dilution |
|
$ |
(0.05 |
) |
$ |
(0.22 |
) |
$ |
0.57 |
|
$ |
0.72 |
|
See accompanying notes to unaudited consolidated financial statements.
4
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY
(Dollars in thousands)
(Unaudited)
|
|
Common |
|
Additional |
|
Unallocated |
|
Accumulated |
|
Retained |
|
Total |
|
||||||
Balance at December 31, 2008, as adjusted |
|
$ |
50,739 |
|
$ |
376,782 |
|
$ |
(6,336 |
) |
$ |
(147,376 |
) |
$ |
223,035 |
|
$ |
496,844 |
|
Cumulative effect of noncredit OTTI, net |
|
|
|
|
|
|
|
(20,094 |
) |
25,240 |
|
5,146 |
|
||||||
Other comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Net income for period |
|
|
|
|
|
|
|
|
|
32,509 |
|
32,509 |
|
||||||
Change in net unrealized investment gains/losses |
|
|
|
|
|
|
|
251,689 |
|
|
|
251,689 |
|
||||||
Noncredit component of OTTI losses, available for sale securities, net |
|
|
|
|
|
|
|
(70,208 |
) |
|
|
(70,208 |
) |
||||||
Other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
213,990 |
|
||||||
Issuance of treasury stock |
|
5 |
|
50 |
|
|
|
|
|
(18 |
) |
37 |
|
||||||
Acquisition of 12,362 shares of common stock |
|
(12 |
) |
(40 |
) |
|
|
|
|
|
|
(52 |
) |
||||||
Allocation of 37,667 shares of common stock by ESOP, including excess income tax benefits |
|
|
|
(114 |
) |
406 |
|
|
|
|
|
292 |
|
||||||
Share-based compensation, including excess income tax benefits |
|
|
|
2,814 |
|
|
|
|
|
|
|
2,814 |
|
||||||
Issuance of 5,000,000 shares of common stock in exchange for notes payable |
|
5,000 |
|
26,226 |
|
|
|
|
|
|
|
31,226 |
|
||||||
Issuance of 132,300 shares of common stock |
|
132 |
|
855 |
|
|
|
|
|
|
|
987 |
|
||||||
Issuance of 339,015 shares of common stock under compensation plans |
|
339 |
|
(339 |
) |
|
|
|
|
|
|
|
|
||||||
Balance at September 30, 2009 |
|
$ |
56,203 |
|
$ |
406,234 |
|
$ |
(5,930 |
) |
$ |
14,011 |
|
$ |
280,766 |
|
$ |
751,284 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Balance at December 31, 2007 |
|
$ |
53,556 |
|
$ |
387,302 |
|
$ |
(6,781 |
) |
$ |
(38,929 |
) |
$ |
216,487 |
|
$ |
611,635 |
|
Retrospective application of accounting for convertible debt |
|
|
|
15,355 |
|
|
|
|
|
(5,888 |
) |
9,467 |
|
||||||
Other comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Net income for period, as adjusted |
|
|
|
|
|
|
|
|
|
39,996 |
|
39,996 |
|
||||||
Change in net unrealized investment gains/losses |
|
|
|
|
|
|
|
(104,227 |
) |
|
|
(104,227 |
) |
||||||
Other comprehensive loss, as adjusted |
|
|
|
|
|
|
|
|
|
|
|
(64,231 |
) |
||||||
Acquisition of 3,734,938 shares of common stock |
|
(3,735 |
) |
(28,875 |
) |
|
|
|
|
|
|
(32,610 |
) |
||||||
Allocation of 29,337 shares of common stock by ESOP, including excess income tax benefits |
|
|
|
(26 |
) |
309 |
|
|
|
|
|
283 |
|
||||||
Share-based compensation, including excess income tax benefits |
|
|
|
2,063 |
|
|
|
|
|
|
|
2,063 |
|
||||||
Issuance of 889,729 shares of common stock under compensation plans, including excess income tax benefits |
|
890 |
|
(626 |
) |
|
|
|
|
|
|
264 |
|
||||||
Conversion of $250 of subordinated debentures |
|
31 |
|
182 |
|
|
|
|
|
|
|
213 |
|
||||||
Balance at September 30, 2008, as adjusted |
|
$ |
50,742 |
|
$ |
375,375 |
|
$ |
(6,472 |
) |
$ |
(143,156 |
) |
$ |
250,595 |
|
$ |
527,084 |
|
See accompanying notes to unaudited consolidated financial statements.
5
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in thousands)
(Unaudited)
|
|
Nine Months Ended |
|
||||
|
|
2009 |
|
2008 |
|
||
|
|
|
|
(As Adjusted) |
|
||
Operating activities |
|
|
|
|
|
||
Net income |
|
$ |
32,509 |
|
$ |
39,996 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
||
Interest sensitive and index product benefits |
|
207,028 |
|
154,032 |
|
||
Amortization of deferred sales inducements |
|
17,814 |
|
34,193 |
|
||
Annuity product charges |
|
(47,501 |
) |
(37,271 |
) |
||
Change in fair value of embedded derivatives |
|
414,636 |
|
(237,969 |
) |
||
Increase in traditional life and accident and health insurance reserves |
|
6,331 |
|
2,724 |
|
||
Policy acquisition costs deferred |
|
(244,164 |
) |
(200,267 |
) |
||
Amortization of deferred policy acquisition costs |
|
44,938 |
|
118,595 |
|
||
Provision for depreciation and other amortization |
|
4,323 |
|
5,250 |
|
||
Amortization of discount and premium on investments |
|
(160,338 |
) |
(195,443 |
) |
||
Trading securities purchases, sales and maturities, net |
|
(360,418 |
) |
|
|
||
Change in restricted cash and short-term investments |
|
(177,149 |
) |
|
|
||
Net realized gains on investments, excluding OTTI losses |
|
(10,587 |
) |
(3,343 |
) |
||
Net OTTI losses recognized in operations |
|
63,656 |
|
94,755 |
|
||
Change in fair value of derivatives |
|
(109,563 |
) |
313,853 |
|
||
Deferred income taxes |
|
(114,669 |
) |
57,891 |
|
||
Loss (gain) on extinguishment of debt |
|
(3,098 |
) |
1,356 |
|
||
Share-based compensation |
|
3,183 |
|
1,920 |
|
||
Change in accrued investment income |
|
(40,865 |
) |
(16,724 |
) |
||
Change in income taxes payable |
|
11,498 |
|
10,721 |
|
||
Change in other assets |
|
(4,111 |
) |
50 |
|
||
Change in other policy funds and contract claims |
|
(515 |
) |
(6,296 |
) |
||
Change in funds withheld reinsurance liability |
|
452,180 |
|
|
|
||
Change in other liabilities |
|
276,056 |
|
12,200 |
|
||
Other |
|
(2,010 |
) |
(309 |
) |
||
Net cash provided by operating activities |
|
259,164 |
|
149,914 |
|
||
|
|
|
|
|
|
||
Investing activities |
|
|
|
|
|
||
Sales, maturities, or repayments of investments: |
|
|
|
|
|
||
Fixed maturity securities - available for sale |
|
2,236,834 |
|
1,094,762 |
|
||
Fixed maturity securities - held for investment |
|
1,918,418 |
|
955,560 |
|
||
Equity securities - available for sale |
|
11,778 |
|
12,211 |
|
||
Mortgage loans on real estate |
|
87,898 |
|
91,446 |
|
||
Derivative instruments |
|
6,534 |
|
29,323 |
|
||
Acquisition of investments: |
|
|
|
|
|
||
Fixed maturity securities - available for sale |
|
(5,987,086 |
) |
(2,575,652 |
) |
||
Equity securities - available for sale |
|
|
|
(102,881 |
) |
||
Mortgage loans on real estate |
|
(149,624 |
) |
(418,293 |
) |
||
Derivative instruments |
|
(189,424 |
) |
(221,702 |
) |
||
Policy loans |
|
(28 |
) |
(10 |
) |
||
Purchases of property, furniture and equipment |
|
(1,001 |
) |
(176 |
) |
||
Net cash used in investing activities |
|
(2,065,701 |
) |
(1,135,412 |
) |
||
6
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
(Dollars in thousands)
(Unaudited)
|
|
Nine Months Ended |
|
||||
|
|
2009 |
|
2008 |
|
||
|
|
|
|
(As Adjusted) |
|
||
Financing activities |
|
|
|
|
|
||
Receipts credited to annuity policyholder account balances |
|
$ |
2,777,615 |
|
$ |
1,735,001 |
|
Coinsurance deposits |
|
(371,897 |
) |
132,761 |
|
||
Return of annuity policyholder account balances |
|
(1,038,657 |
) |
(975,384 |
) |
||
Financing fees incurred and deferred |
|
(320 |
) |
|
|
||
Proceeds from notes payable |
|
75,000 |
|
40,000 |
|
||
Repayments of notes payable |
|
(3,082 |
) |
(35,353 |
) |
||
Increase in amounts due under repurchase agreements |
|
410,254 |
|
115,914 |
|
||
Acquisition of common stock |
|
(34 |
) |
(27,051 |
) |
||
Excess tax benefits realized from share-based compensation plans |
|
63 |
|
197 |
|
||
Proceeds from issuance of common stock |
|
987 |
|
219 |
|
||
Change in checks in excess of cash balance |
|
(8,404 |
) |
(2,302 |
) |
||
Other |
|
12 |
|
|
|
||
Net cash provided by financing activities |
|
1,841,537 |
|
984,002 |
|
||
Increase (decrease) in cash and cash equivalents |
|
35,000 |
|
(1,496 |
) |
||
|
|
|
|
|
|
||
Cash and cash equivalents at beginning of period |
|
214,862 |
|
18,888 |
|
||
Cash and cash equivalents at end of period |
|
$ |
249,862 |
|
$ |
17,392 |
|
|
|
|
|
|
|
||
Supplemental disclosures of cash flow information |
|
|
|
|
|
||
Cash paid during period for: |
|
|
|
|
|
||
Interest expense |
|
$ |
19,669 |
|
$ |
30,228 |
|
Income taxes |
|
117,850 |
|
|
|
||
Non-cash operating activity: |
|
|
|
|
|
||
Deferral of sales inducements |
|
229,739 |
|
145,595 |
|
||
Non-cash investing activity: |
|
|
|
|
|
||
Real estate acquired in satisfaction of mortgage loans |
|
8,949 |
|
|
|
||
Non-cash financing activities: |
|
|
|
|
|
||
Conversion of subordinated debentures |
|
|
|
213 |
|
||
Stock acquired in satisfaction of obligations |
|
|
|
5,559 |
|
||
Stock issued in extinguishment of debt |
|
31,250 |
|
|
|
See accompanying notes to unaudited consolidated financial statements.
7
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2009
(Unaudited)
1. Organization and Significant Accounting Policies
Consolidation and Basis of Presentation
The accompanying consolidated financial statements of American Equity Investment Life Holding Company (we, us or our) have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and notes required by GAAP for complete financial statements. The consolidated financial statements reflect all adjustments, consisting only of normal recurring items, which are necessary to present fairly our financial position and results of operations on a basis consistent with the prior audited consolidated financial statements. Operating results for the three month and nine month periods ended September 30, 2009 are not necessarily indicative of the results that may be expected for the year ended December 31, 2009. All significant intercompany accounts and transactions have been eliminated. The preparation of financial statements requires the use of management estimates. For further information related to a description of areas of judgment and estimates and other information necessary to understand our financial position and results of operations, refer to the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December 31, 2008.
Reclassifications have been made to prior period financial statements to conform with the September 30, 2009 presentation. See Adopted Accounting Pronouncements for impact of new accounting guidance on prior period financial statements.
Restricted Cash and Short-Term Investments
We consider all cash and short term investments held that we are legally restricted from using in our normal operations and investing activities as restricted cash. The restricted cash at September 30, 2009 is cash and short term investments held in trust as funds withheld in connection with coinsurance agreements.
Adopted Accounting Pronouncements
On January 1, 2009, we adopted accounting standards that enhance the required disclosures regarding derivatives and hedging activities, including enhanced disclosures regarding how an entity uses derivative instruments and how derivative instruments and related hedged items are accounted for and affect an entitys financial position, financial performance and cash flows. The adoption of these disclosure requirements did not have a material impact on our financial position or results of operations as it impacts financial statement disclosure only.
In April 2009, the Financial Accounting Standards Board (FASB) issued further guidance on the recognition and presentation of other than temporary impairments. This guidance amends the other than temporary impairment guidance for debt securities only to make the guidance more operational and to expand the presentation and disclosure of other than temporary impairments on debt and equity securities in the financial statements. This guidance requires management to determine cash flows expected to be collected on each debt security for which an other than temporary impairment is being recognized. In accordance with this guidance, the reporting entity shall allocate its other than temporary impairments on debt securities between credit and noncredit components with the noncredit portion of the other than temporary impairments recognized as a component of other comprehensive income (loss) and the credit loss portion included in operations. Credit loss is defined as the amount that the amortized cost basis of the impaired security exceeds the present value of cash flows
8
expected to be collected. This guidance also requires a cumulative effect adjustment to the opening balance of retained earnings and accumulated other comprehensive income (loss) in the period of adoption for other than temporary impairments on debt securities recognized in prior periods which are still held as investments at the date of adoption. This guidance was effective for interim and annual reporting periods ending after June 15, 2009; however, early application was permitted. We elected to adopt these accounting standards effective January 1, 2009. The cumulative effect adjustment as of January 1, 2009 increased retained earnings by $25.2 million and decreased accumulated other comprehensive income by $20.1 million.
In April 2009, the FASB issued additional guidance for estimating fair value of financial instruments including investment securities when the volume and level of activity for the asset or liability have significantly decreased, as well as guidance on identifying circumstances that indicate a transaction is not orderly. This guidance was effective for interim and annual reporting periods ending after June 15, 2009, and shall be applied prospectively, with early adoption permitted. We elected to adopt this guidance as of January 1, 2009, and it did not have a material impact on our consolidated financial statements.
On January 1, 2009, we adopted and applied retrospectively to all periods presented an accounting standard for convertible debt instruments that may be settled in whole or in part with cash. This standard specifies that issuers of such instruments should separately account for the liability component and the equity component represented by the embedded conversion option in a manner that will reflect the issuers nonconvertible debt borrowing rate when interest cost is recognized in subsequent periods. Upon settlement, the issuer shall allocate consideration transferred and transaction costs incurred to the extinguishment of the liability component and the reacquisition of the equity component.
In December 2004, we issued $260 million of contingent convertible senior notes with a fixed rate of 5.25% and a maturity date of December 6, 2024. On the date of issuance bifurcation of these notes into a debt component and an equity component is required. The difference between the fair value of the debt component at the date of issuance and the initial proceeds at the date of issuance is recorded as a component of equity. The fair value of the notes without the embedded conversion option (liability component) at the date of issuance was $221.4 million. The fair value of the embedded conversion option (equity component) at the date of issuance was $39.1 million. The fair value of the equity component at issuance has been recorded as a debt discount to the notes, with a corresponding increase to additional paid-in capital, net of income tax. The debt discount is being amortized over the expected life of the debt.
The following summarizes the effects of the retrospective adoption of the accounting for convertible debt on the balance sheet, statements of operations and earnings per share:
|
|
December 31, 2008 |
|
|||||||
|
|
As Originally |
|
Adjustments |
|
As Adjusted |
|
|||
|
|
(Dollars in thousands) |
|
|||||||
Deferred income taxes |
|
$ |
85,700 |
|
$ |
(3,291 |
) |
$ |
82,409 |
|
Other assets |
|
23,661 |
|
(2,782 |
) |
20,879 |
|
|||
Total assets |
|
17,087,813 |
|
(6,073 |
) |
17,081,740 |
|
|||
|
|
|
|
|
|
|
|
|||
Notes payable |
|
258,462 |
|
(10,712 |
) |
247,750 |
|
|||
Total liabilities |
|
16,595,608 |
|
(10,712 |
) |
16,584,896 |
|
|||
|
|
|
|
|
|
|
|
|||
Additional paid-in capital |
|
361,427 |
|
15,355 |
|
376,782 |
|
|||
Retained earnings |
|
233,751 |
|
(10,716 |
) |
223,035 |
|
|||
Total stockholders equity |
|
492,205 |
|
4,639 |
|
496,844 |
|
|||
9
|
|
Three Months Ended September 30, 2008 |
|
Nine Months Ended September 30, 2008 |
|
||||||||||||||
|
|
As Originally |
|
Adjustments |
|
As |
|
As Originally |
|
Adjustments |
|
As Adjusted |
|
||||||
|
|
(Dollars in thousands, except per share data) |
|
||||||||||||||||
Gain (loss) on extinguishment of debt (1) |
|
$ |
59 |
|
$ |
(87 |
) |
$ |
(28 |
) |
$ |
242 |
|
$ |
(1,598 |
) |
$ |
(1,356 |
) |
Interest expense on notes payable |
|
3,881 |
|
1,133 |
|
5,014 |
|
11,732 |
|
3,395 |
|
15,127 |
|
||||||
Income tax expense |
|
28,608 |
|
(506 |
) |
28,102 |
|
57,286 |
|
(2,072 |
) |
55,214 |
|
||||||
Net income (loss) |
|
(11,002 |
) |
(714 |
) |
(11,716 |
) |
42,917 |
|
(2,921 |
) |
39,996 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Earnings per common share |
|
$ |
(0.21 |
) |
$ |
(0.01 |
) |
$ |
(0.22 |
) |
$ |
0.79 |
|
$ |
(0.05 |
) |
$ |
0.74 |
|
Earnings per common share - assuming dilution |
|
$ |
(0.21 |
) |
$ |
(0.01 |
) |
$ |
(0.22 |
) |
$ |
0.77 |
|
$ |
(0.05 |
) |
$ |
0.72 |
|
(1) the gain on extinguishment of debt was originally reported as part of other operating costs and expenses in the consolidated statements of operations for the three and nine months ended September 30, 2008.
In May 2009, the FASB issued an accounting standard that requires reporting entities to recognize in their financial statements the effects of all subsequent events that provide additional evidence about conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing those financial statements. In addition, a reporting entity shall disclose the date through which subsequent events have been evaluated, as well as whether that date is the date the financial statements were issued or the date the financial statements were available to be issued. These requirements were effective for periods ending after June 15, 2009. Accordingly, we adopted the subsequent event reporting requirements effective June 30, 2009 and it did not have a material effect on our consolidated financial statements.
In April 2009, the FASB issued disclosure guidance that requires disclosures about fair value of financial instruments within the scope of existing standards for interim reporting periods as well as in annual financial statements. This guidance also requires entities to disclose the methods and significant assumptions used to estimate the fair value of financial instruments in financial statements on an interim and annual basis and to highlight any changes from prior periods and was effective for financial statements issued for interim and annual periods ending after June 15, 2009. We adopted these disclosure requirements as of and for the periods ended June 30, 2009.
New Accounting Pronouncements
In June 2009, the FASB amended accounting standards for transfers and servicing of financial assets and extinguishments of liabilities. The new standards removes the concept of a qualifying special-purpose entity (QSPE) from existing standards and removes the exception of QSPEs from consolidation requirements. Additionally, more stringent conditions for reporting a transfer of a portion of a financial asset as a sale were created, derecognition criteria was clarified, how retained interests are initially measured was revised, the guaranteed mortgage securitization recharacterization provisions were removed and disclosure requirements were added. This standard must be applied as of the beginning of our first annual reporting period that begins after November 15, 2009, for interim periods within that first annual reporting period and for interim and annual reporting periods thereafter. Earlier application is prohibited. We are currently assessing the impact of this standard.
In June 2009, the FASB issued amendments to the accounting standards for consolidation of variable interest entities. The new standard replaces the quantitative-based risks and rewards calculation of existing standards for determining which enterprise, if any, has a controlling financial interest in a variable interest entity with a primarily qualitative approach focused on identifying which enterprise has the power to direct the activities of a variable interest entity that most significantly impacts the entitys economic performance and (1) the obligation to absorb losses of the entity or (2) the right to receive benefits from the entity. This amendment is effective as of the beginning of each reporting entitys first annual reporting period that begins after November 15, 2009, for interim periods within that first annual reporting period and for interim and annual reporting periods thereafter. Earlier application is prohibited. We are currently assessing the impact of this standard.
In September 2009, the FASB issued an accounting standards update that allows for net asset value per share to be used as a means to estimate fair value for an investment if the fair value of that investment is not readily determinable. Investments that qualify are those that calculate a net asset value per share or its equivalent as of the investors measurement date. This standard is effective for interim and annual periods ending after December 15, 2009, with early application permitted. We are currently assessing the impact of this accounting standards update.
In August 2009, the FASB issued an accounting standards update that amends the fair value measurement of liabilities. The update provides clarification that in circumstances in which a quoted price in an active market for
10
the identical liability is not available, a reporting entity is required to measure fair value using the quoted price of the identical liability when traded as an asset, quoted prices for similar liabilities or similar liabilities when traded as assets, or another valuation technique that is consistent with the principles of fair value. This guidance is effective for the first reporting period beginning after issuance, which will be our three months and year ending December 31, 2009. We are currently assessing the impact of this accounting standards update.
2. Other Comprehensive Income (Loss)
Other comprehensive income (loss) is as follows:
|
|
Three Months Ended |
|
Nine Months Ended |
|
||||||||
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
|
||||
|
|
(Dollars in thousands) |
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||
Net income (loss) |
|
$ |
(2,978 |
) |
$ |
(11,716 |
) |
$ |
32,509 |
|
$ |
39,996 |
|
Change in net unrealized investment gains/losses |
|
171,044 |
|
(54,731 |
) |
251,689 |
|
(104,227 |
) |
||||
Noncredit component of OTTI losses, available for sale securities, net |
|
(32,267 |
) |
|
|
(70,208 |
) |
|
|
||||
|
|
$ |
135,799 |
|
$ |
(66,447 |
) |
$ |
213,990 |
|
$ |
(64,231 |
) |
3. Fair Values of Financial Instruments
Fair value is the price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The objective of a fair value measurement is to determine that price for each financial instrument at each measurement date. We meet this objective using various methods of valuation that include market, income and cost approaches.
We categorize our financial instruments into three levels of fair value hierarchy based on the priority for use of inputs in determining fair value. The hierarchy defines the highest priority inputs (Level 1) as quoted prices in active markets for identical assets. The lowest priority inputs (Level 3) are our own assumptions about what a market participant would use in determining fair value such as estimated future cash flows. We categorize financial assets and liabilities recorded at fair value in the consolidated balance sheets as follows:
Level 1 - Quoted prices are available in active markets for identical financial instruments as of the reporting date. The types of financial instruments included in Level 1 are listed equities, United States treasuries and non-interest bearing cash. We do not adjust the quoted price for these financial instruments, even in situations where we hold a large position and a sale could reasonably impact the quoted price.
Level 2 - Quoted prices in active markets for similar financial instruments, quoted prices for identical or similar financial instruments in markets that are not active; and models and other valuation methodologies using inputs other than quoted prices that are observable. The types of financial instruments included in Level 2 are U.S. Government sponsored agency securities, corporate preferred securities, corporate bonds and mortgage and asset backed securities.
Level 3 - Models and other valuation methodologies using significant inputs that are unobservable for financial instruments and include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value require significant management judgment or estimation. Financial instruments that are included in Level 3 are securities for which no market activity or data exists and for which we used discounted expected future cash flows with our own assumptions about what a market participant would use in determining fair value.
We used the following valuation techniques in estimating the fair values of financial instruments:
I. Fair values of fixed maturity securities are obtained primarily from a broker who starts by obtaining a price from an independent pricing source and adjusts for observable data. These prices from the independent broker undergo
11
evaluation by our internal investment professionals. We generally obtain one price per security, which is compared to relevant credit information, perceived market movements and sector news. Market indices of similar rated asset class spreads are considered for valuations and broker indications of similar securities are compared. Inputs used by both the broker and the pricing service include market information, such as yield data and other factors relating to instruments or securities with similar characteristics. If the issuer has had trades in similar debt outstanding but not necessarily the same rank in the capital structure, spread information is used to support fair value. If discrepancies are identified, additional quotes are obtained and the quote that best reflects a fair value exit price at the reporting date is selected. In the case of private placement bonds, the broker typically starts with a price of a publicly traded bond of an entity that is comparable to size and financial position of the issuer of the private bond. The broker adjusts the price for factors such as marketability and risk factors specific to each security.
II. Amounts reported as fair value of embedded derivatives are estimated by projecting policy contract values and minimum guaranteed contract values over the expected lives of the contracts and discounting the excess of the projected contract value amounts. The projections of the policy contract values are based on best estimate assumptions for future policy growth and future policy decrements. Best estimate assumptions for future policy growth include assumptions for the expected index credit on the next policy anniversary date which are derived from the fair values of the underlying call options purchased to fund such index credits and the expected costs of annual call options that will be purchased in the future to fund index credits beyond the next policy anniversary. The projections of minimum guaranteed contract values include the same best estimate assumptions for policy decrements as were used to project policy contract values. Increases or decreases in the fair value of embedded derivatives generally correspond to increases or decreases in the fair values of call options purchased to fund the annual index credits and changes in the discount rates used to discount the excess of the projected policy contract values over the projected minimum guaranteed contract values. The fair value of the embedded derivatives includes an adjustment through the discount rate for our non performance risk.
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, a financial instruments level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument.
We review the prices received from the independent brokers to ensure that the prices represent a reasonable estimate of fair value. This process involves quantitative and qualitative analysis and is administered by our investment department. This review process includes, but is not limited to, initial and on-going review of methodologies used by the independent broker, review of pricing statistics and trends, back testing recent trades, comparing prices to those obtained from other third party pricing services, reviewing cash flow activity in the subsequent period, monitoring credit rating upgrades and downgrades and monitoring of trading volumes. Most all of the information used by the pricing service and the independent broker can be corroborated by our procedures of investigating market data and tying that data to the facts utilized by the broker.
The fixed income markets in 2008 and early 2009 experienced a period of extreme volatility and limited market liquidity conditions, which affected a broad range of asset classes and sectors. In addition, there were credit downgrade events and an increased probability of default for many fixed income instruments. These volatile market conditions increased the difficulty of valuing certain instruments as trading was less frequent and/or market data was less observable. There were certain instruments that were in active markets with significant observable data that became illiquid due to the current financial environment or market conditions. As a result, certain valuations require greater estimation and judgment as well as valuation methods which are more complex. These values may not ultimately be realizable in a market transaction, and such values may change very rapidly as market conditions change and valuation assumptions are modified.
The following methods and assumptions were used in estimating the fair values of financial instruments during the periods presented in these consolidated financial statements.
Fixed maturity securities and trading securities: The fair values of fixed maturity securities and trading securities are obtained from third parties and are based on quoted market prices when available. The third parties use yield data and other factors relating to instruments or securities with similar characteristics to determine fair value for securities that are not actively traded.
Equity securities: The fair values of equity securities are based on quoted market prices.
12
Mortgage loans on real estate: The fair values of mortgage loans on real estate are calculated using discounted expected cash flows using current competitive market interest rates currently being offered for similar loans.
Derivative instruments: The fair values of our derivative instruments are based upon the amount of cash that we will receive to settle each derivative instrument on the reporting date. These amounts are obtained from each of the counterparties and are adjusted for the non-performance risk of each counterparty net of any collateral held. The non-performance risk for each counterparty is based upon its credit default swap rate. We have no performance obligations related to the call options purchased to fund our index annuity policy liabilities.
Other investments: Other investments is comprised of policy loans and real estate held for sale. We have not attempted to determine the fair values associated with our policy loans, as management believes any differences between carrying value and the fair values afforded these instruments are immaterial to our financial position and, accordingly, the cost to provide such disclosure is not worth the benefit to be derived. The fair value of our real estate held for sale was determined by estimating the net operating income of the commercial rental property and dividing that by a current market capitalization rate.
Cash and cash equivalents and restricted cash: Amounts reported in the consolidated balance sheets for these instruments are reported at their historical cost which approximates fair value due to the nature of the assets assigned to this category.
Annuity policy benefit reserves and coinsurance deposits: The fair values of the liabilities under contracts not involving significant mortality or morbidity risks (principally deferred annuities), are stated at the cost we would incur to extinguish the liability (i.e., the cash surrender value). The coinsurance deposits related to the annuity benefit reserves have fair values determined in a similar fashion. We are not required to and have not estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value.
Notes payable and amounts due under repurchase agreements: The fair value of the contingent convertible senior notes is based upon quoted market prices. Fair values for other notes payable with fixed interest rates are estimated by discounting expected cash flows using current market interest rates currently being offered for similar securities. The amounts reported in the consolidated balance sheets for short term indebtedness under repurchase agreements with variable interest rates approximate their fair values.
Subordinated debentures: The carrying amount of subordinated debentures with variable interest rates reported in the consolidated balance sheets approximates fair value. Fair values for subordinated debentures with fixed interest rates are estimated by discounting expected cash flows using current market interest rates currently being offered for similar securities.
The following sets forth a comparison of the fair values and carrying amounts of our financial instruments:
|
|
September 30, 2009 |
|
December 31, 2008 |
|
||||||||
|
|
Carrying |
|
Fair Value |
|
Carrying |
|
|
|
||||
|
|
|
|
(Dollars in thousands) |
|
|
|
||||||
Assets |
|
|
|
|
|
|
|
|
|
||||
Fixed maturity securities: |
|
|
|
|
|
|
|
|
|
||||
Available for sale |
|
$ |
11,082,957 |
|
$ |
11,082,957 |
|
$ |
6,629,046 |
|
$ |
6,629,046 |
|
Held for investment |
|
1,758,747 |
|
1,746,033 |
|
3,604,149 |
|
3,588,114 |
|
||||
Equity securities, available for sale |
|
94,076 |
|
94,076 |
|
99,552 |
|
99,552 |
|
||||
Mortgage loans on real estate |
|
2,375,833 |
|
2,338,065 |
|
2,329,824 |
|
2,284,583 |
|
||||
Derivative instruments |
|
364,041 |
|
364,041 |
|
56,588 |
|
56,588 |
|
||||
Trading securities |
|
371,338 |
|
371,338 |
|
|
|
|
|
||||
Other investments |
|
9,332 |
|
9,332 |
|
446 |
|
446 |
|
||||
Cash and cash equivalents |
|
249,862 |
|
249,862 |
|
214,862 |
|
214,862 |
|
||||
Restricted cash and short-term investments |
|
177,149 |
|
177,149 |
|
|
|
|
|
||||
Coinsurance deposits |
|
2,010,084 |
|
1,726,909 |
|
1,528,981 |
|
1,366,149 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Liabilities |
|
|
|
|
|
|
|
|
|
||||
Annuity benefit reserves |
|
18,331,332 |
|
15,539,193 |
|
15,687,625 |
|
13,391,244 |
|
||||
Notes payable |
|
287,697 |
|
285,661 |
|
247,750 |
|
193,267 |
|
||||
Subordinated debentures |
|
268,312 |
|
208,256 |
|
268,209 |
|
248,283 |
|
||||
Amounts due under repurchase agreements |
|
410,254 |
|
410,254 |
|
|
|
|
|
||||
Interest rate swaps |
|
2,227 |
|
2,227 |
|
|
|
|
|
||||
13
Our assets and liabilities which are measured at fair value on a recurring basis as of September 30, 2009 and December 31, 2008 are presented below based on the fair value hierarchy levels:
|
|
Total |
|
Quoted |
|
Significant |
|
Significant |
|
||||
|
|
(Dollars in thousands) |
|
||||||||||
September 30, 2009 |
|
|
|
|
|
|
|
|
|
||||
Assets |
|
|
|
|
|
|
|
|
|
||||
Fixed maturity securities: |
|
|
|
|
|
|
|
|
|
||||
Available for sale: |
|
|
|
|
|
|
|
|
|
||||
United States Government full faith and credit |
|
$ |
3,292 |
|
$ |
2,585 |
|
$ |
707 |
|
$ |
|
|
United States Government sponsored agencies |
|
4,224,437 |
|
|
|
4,224,437 |
|
|
|
||||
U.S. states, territories and political subdivisions |
|
305,128 |
|
|
|
305,128 |
|
|
|
||||
Corporate securities |
|
3,966,748 |
|
69,502 |
|
3,879,464 |
|
17,782 |
|
||||
Mortgage and asset backed securities |
|
2,583,351 |
|
|
|
2,580,704 |
|
2,647 |
|
||||
Equity securities, available for sale: finance, insurance and real estate |
|
94,073 |
|
85,665 |
|
8,408 |
|
|
|
||||
Trading securities |
|
371,338 |
|
|
|
371,338 |
|
|
|
||||
Derivative instruments |
|
364,041 |
|
|
|
364,041 |
|
|
|
||||
Cash and cash equivalents |
|
249,862 |
|
249,862 |
|
|
|
|
|
||||
Restricted cash and short-term investments |
|
177,149 |
|
177,149 |
|
|
|
|
|
||||
|
|
$ |
12,339,419 |
|
$ |
584,763 |
|
$ |
11,734,227 |
|
$ |
20,429 |
|
Liabilities |
|
|
|
|
|
|
|
|
|
||||
Interest rate swaps |
|
$ |
2,227 |
|
$ |
|
|
$ |
2,227 |
|
$ |
|
|
Index annuities-embedded derivatives |
|
1,248,912 |
|
|
|
|
|
1,248,912 |
|
||||
|
|
$ |
1,251,139 |
|
$ |
|
|
$ |
2,227 |
|
$ |
1,248,912 |
|
|
|
|
|
|
|
|
|
|
|
||||
December 31, 2008 |
|
|
|
|
|
|
|
|
|
||||
Assets |
|
|
|
|
|
|
|
|
|
||||
Fixed maturity securities: |
|
|
|
|
|
|
|
|
|
||||
Available for sale: |
|
|
|
|
|
|
|
|
|
||||
United States Government full faith and credit |
|
$ |
22,050 |
|
$ |
3,404 |
|
$ |
18,646 |
|
$ |
|
|
United States Government sponsored agencies |
|
3,104,853 |
|
|
|
3,104,853 |
|
|
|
||||
Corporate securities |
|
1,688,869 |
|
84,946 |
|
1,586,174 |
|
17,749 |
|
||||
Mortgage and asset backed securities |
|
1,813,274 |
|
|
|
1,810,941 |
|
2,333 |
|
||||
Equity securities, available for sale: finance, insurance and real estate |
|
99,552 |
|
84,554 |
|
14,998 |
|
|
|
||||
Derivative instruments |
|
56,588 |
|
|
|
56,588 |
|
|
|
||||
Cash and cash equivalents |
|
214,862 |
|
214,862 |
|
|
|
|
|
||||
|
|
$ |
7,000,048 |
|
$ |
387,766 |
|
$ |
6,592,200 |
|
$ |
20,082 |
|
Liabilities |
|
|
|
|
|
|
|
|
|
||||
Index annuities-embedded derivatives |
|
$ |
998,015 |
|
$ |
|
|
$ |
|
|
$ |
998,015 |
|
14
The following tables provide a reconciliation of the beginning and ending balances for our Level 3 assets and liabilities, which are measured at fair value on a recurring basis using significant unobservable inputs for the three and nine months ended September 30, 2009 and 2008:
|
|
Three Months Ended |
|
Nine Months Ended |
|
||||||||
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
|
||||
|
|
(Dollars in thousands) |
|
||||||||||
Available for sale securities |
|
|
|
|
|
|
|
|
|
||||
Beginning balance |
|
$ |
19,140 |
|
$ |
19,099 |
|
$ |
20,082 |
|
$ |
|
|
Transfers in to or out of Level 3 |
|
|
|
2,364 |
|
|
|
29,398 |
|
||||
Disposals |
|
(52 |
) |
|
|
(126 |
) |
|
|
||||
Total gains (losses) (unrealized/realized): |
|
|
|
|
|
|
|
|
|
||||
Included in other comprehensive income |
|
1,628 |
|
(4,664 |
) |
1,586 |
|
(4,664 |
) |
||||
Net OTTI losses recognized in operations |
|
(287 |
) |
|
|
(1,113 |
) |
(7,935 |
) |
||||
|
|
$ |
20,429 |
|
$ |
16,799 |
|
$ |
20,429 |
|
$ |
16,799 |
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Three
Months Ended |
|
Nine
Months Ended |
|
||||||||
|
|
2009 |
|
2008 |
|
2009 |
|
2008 |
|
||||
|
|
(Dollars in thousands) |
|
||||||||||
Index annuities-embedded derivatives |
|
|
|
|
|
|
|
|
|
||||
Beginning balance |
|
$ |
1,050,769 |
|
$ |
1,168,050 |
|
$ |
998,015 |
|
$ |
1,432,746 |
|
Reinsurance adjustment |
|
(14,567 |
) |
|
|
(14,567 |
) |
|
|
||||
Premiums less benefits |
|
2,377 |
|
2,478 |
|
(2,464 |
) |
71,463 |
|
||||
Change in unrealized losses (gains), net |
|
210,333 |
|
(102,533 |
) |
267,928 |
|
(436,214 |
) |
||||
|
|
$ |
1,248,912 |
|
$ |
1,067,995 |
|
$ |
1,248,912 |
|
$ |
1,067,995 |
|
Change in unrealized losses (gains), net for each period in our embedded derivatives are included in change in fair value of embedded derivatives in the consolidated statements of operations.
15
4. Investments
At September 30, 2009 and December 31, 2008, the amortized cost and fair value of fixed maturity securities and equity securities were as follows:
|
|
Amortized |
|
Gross |
|
Gross |
|
Fair Value |
|
||||
|
|
(Dollars in thousands) |
|
||||||||||
September 30, 2009 |
|
|
|
|
|
|
|
|
|
||||
Fixed maturity securities: |
|
|
|
|
|
|
|
|
|
||||
Available for sale: |
|
|
|
|
|
|
|
|
|
||||
United States Government full faith and credit |
|
$ |
3,000 |
|
$ |
292 |
|
$ |
|
|
$ |
3,292 |
|
United States Government sponsored agencies |
|
4,233,286 |
|
13,345 |
|
(22,195 |
) |
4,224,436 |
|
||||
U.S. states, territories and political subdivisions |
|
287,926 |
|
17,245 |
|
(42 |
) |
305,129 |
|
||||
Corporate securities |
|
3,737,905 |
|
314,766 |
|
(85,923 |
) |
3,966,748 |
|
||||
Mortgage and asset backed securities |
|
2,885,262 |
|
58,010 |
|
(359,920 |
) |
2,583,352 |
|
||||
|
|
$ |
11,147,379 |
|
$ |
403,658 |
|
$ |
(468,080 |
) |
$ |
11,082,957 |
|
|
|
|
|
|
|
|
|
|
|
||||
Held for investment: |
|
|
|
|
|
|
|
|
|
||||
United States Government sponsored agencies |
|
$ |
1,683,131 |
|
$ |
5,682 |
|
$ |
(136 |
) |
$ |
1,688,677 |
|
Corporate security |
|
75,616 |
|
|
|
(18,260 |
) |
57,356 |
|
||||
|
|
$ |
1,758,747 |
|
$ |
5,682 |
|
$ |
(18,396 |
) |
$ |
1,746,033 |
|
|
|
|
|
|
|
|
|
|
|
||||
Equity securities, available for sale: |
|
|
|
|
|
|
|
|
|
||||
Finance, insurance and real estate |
|
$ |
84,512 |
|
$ |
13,411 |
|
$ |
(3,847 |
) |
$ |
94,076 |
|
|
|
|
|
|
|
|
|
|
|
||||
December 31, 2008 |
|
|
|
|
|
|
|
|
|
||||
Fixed maturity securities: |
|
|
|
|
|
|
|
|
|
||||
Available for sale: |
|
|
|
|
|
|
|
|
|
||||
United States Government full faith and credit |
|
$ |
21,664 |
|
$ |
515 |
|
$ |
(129 |
) |
$ |
22,050 |
|
United States Government sponsored agencies |
|
3,090,458 |
|
15,528 |
|
(1,133 |
) |
3,104,853 |
|
||||
Corporate securities |
|
1,951,308 |
|
14,939 |
|
(277,378 |
) |
1,688,869 |
|
||||
Mortgage and asset backed securities |
|
2,095,856 |
|
6,055 |
|
(288,637 |
) |
1,813,274 |
|
||||
|
|
$ |
7,159,286 |
|
$ |
37,037 |
|
$ |
(567,277 |
) |
$ |
6,629,046 |
|
|
|
|
|
|
|
|
|
|
|
||||
Held for investment: |
|
|
|
|
|
|
|
|
|
||||
United States Government sponsored agencies |
|
$ |
3,528,628 |
|
$ |
6,421 |
|
$ |
(4,984 |
) |
$ |
3,530,065 |
|
Corporate security |
|
75,521 |
|
|
|
(17,472 |
) |
58,049 |
|
||||
|
|
$ |
3,604,149 |
|
$ |
6,421 |
|
$ |
(22,456 |
) |
$ |
3,588,114 |
|
|
|
|
|
|
|
|
|
|
|
||||
Equity securities, available for sale: |
|
|
|
|
|
|
|
|
|
||||
Finance, insurance and real estate |
|
$ |
125,157 |
|
$ |
373 |
|
$ |
(25,978 |
) |
$ |
99,552 |
|
During the nine months ended September 30, 2009 and 2008, we received $3.6 billion and $1.5 billion, respectively, in net redemption proceeds related to calls of our callable United States Government sponsored agency securities, of which $1.9 billion and $1.0 billion, respectively, were classified as held for investment. We reinvested the proceeds from these redemptions primarily in United States Government sponsored agency securities, corporate securities and mortgage backed securities classified as available for sale. At September 30, 2009, 50% of our fixed income securities have call features and 8% were subject to call redemption. Another 9% will become subject to call redemption through December 31, 2009.
16
The amortized cost and fair value of fixed maturity securities at September 30, 2009, by contractual maturity, are shown below. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. All of our mortgage and asset backed securities provide for periodic payments throughout their lives and are shown below as a separate line.
|
|
Available for sale |
|
Held for investment |
|
||||||||
|
|
Amortized |
|
Fair Value |
|
Amortized |
|
Fair Value |
|
||||
|
|
(Dollars in thousands) |
|
||||||||||
Due in one year or less |
|
$ |
26,586 |
|
$ |
25,896 |
|
$ |
|
|
$ |
|
|
Due after one year through five years |
|
399,912 |
|
417,416 |
|
|
|
|
|
||||
Due after five years through ten years |
|
1,445,204 |
|
1,573,290 |
|
|
|
|
|
||||
Due after ten years through twenty years |
|
1,831,095 |
|
1,852,315 |
|
555,000 |
|
555,981 |
|
||||
Due after twenty years |
|
4,559,320 |
|
4,630,688 |
|
1,203,747 |
|
1,190,052 |
|
||||
|
|
8,262,117 |
|
8,499,605 |
|
1,758,747 |
|
1,746,033 |
|
||||
Mortgage and asset backed securities |
|
2,885,262 |
|
2,583,352 |
|
|
|
|
|
||||
|
|
$ |
11,147,379 |
|
$ |
11,082,957 |
|
$ |
1,758,747 |
|
$ |
1,746,033 |
|
Net unrealized losses on available for sale fixed maturity securities and equity securities reported as a separate component of stockholders equity were comprised of the following:
|
|
September 30, |
|
December 31, |
|
||
|
|
(Dollars in thousands) |
|
||||
Net unrealized losses on available for sale fixed maturity securities and equity securities |
|
$ |
(54,859 |
) |
$ |
(555,845 |
) |
Adjustments for assumed changes in amortization of deferred policy acquisition costs and deferred sales inducements |
|
28,965 |
|
329,113 |
|
||
Deferred tax valuation allowance reversal |
|
30,842 |
|
|
|
||
Deferred income tax asset |
|
9,063 |
|
79,356 |
|
||
Net unrealized losses reported as accumulated other comprehensive income (loss) |
|
$ |
14,011 |
|
$ |
(147,376 |
) |
The National Association of Insurance Commissioners (NAIC) assigns designations to fixed maturity securities. These designations range from Class 1 (highest quality) to Class 6 (lowest quality). In general, securities are assigned a designation based upon the ratings they are given by the Nationally Recognized Statistical Rating Organizations (NRSROs). The NAIC designations are utilized by insurers in preparing their annual statutory statements. NAIC Class 1 and 2 designations are considered investment grade while NAIC Class 3 through 6 designations are considered non-investment grade. We had 90% and 96% of our fixed maturity portfolio rated investment grade at September 30, 2009 and December 31, 2008, respectively.
The following table summarizes the credit quality, as determined by NAIC designation, of our fixed maturity portfolio and displays the equivalent NRSRO rating as of the dates indicated:
|
|
|
|
September 30, 2009 |
|
December 31, 2008 |
|
||||||||
NAIC |
|
NRSRO Equivalent |
|
Amortized |
|
Fair |
|
Amortized |
|
Fair |
|
||||
|
|
|
|
|
|
(Dollars in thousands) |
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
1 |
|
Aaa/Aa/A |
|
$ |
9,104,618 |
|
$ |
9,226,240 |
|
$ |
8,764,338 |
|
$ |
8,512,209 |
|
2 |
|
Baa |
|
2,221,614 |
|
2,325,360 |
|
1,509,399 |
|
1,292,303 |
|
||||
3 |
|
Ba |
|
343,704 |
|
293,539 |
|
276,519 |
|
208,122 |
|
||||
4 |
|
B |
|
210,541 |
|
185,126 |
|
140,754 |
|
135,989 |
|
||||
5 |
|
Caa and lower |
|
689,830 |
|
548,962 |
|
35,391 |
|
31,375 |
|
||||
6 |
|
In or near default |
|
335,819 |
|
249,763 |
|
37,034 |
|
37,162 |
|
||||
|
|
|
|
$ |
12,906,126 |
|
$ |
12,828,990 |
|
$ |
10,763,435 |
|
$ |
10,217,160 |
|
17
The following tables show our investments gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities (consisting of 280 and 394 securities, respectively) have been in a continuous unrealized loss position, at September 30, 2009 and December 31, 2008:
|
|
Less than 12 months |
|
12 months or more |
|
Total |
|
||||||||||||
|
|
Fair Value |
|
Unrealized |
|
Fair Value |
|
Unrealized |
|
Fair Value |
|
Unrealized |
|
||||||
|
|
(Dollars in thousands) |
|
||||||||||||||||
September 30, 2009 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Fixed maturity securities: |
|
|
|
|
|
|